6 results for “First-Line-Drugs”

Set a search alert

Research ArticleOpen accessIn the keywordsMycobacterium tuberculosis Complex Mutations in Drug Resistant Clinical Isolates from Southwest MexicoMartínez-Cruz Perla Mónica, Nakamura-López Yuko, Quintero-Hernández Verónica et al.Mutations in target genes have been described in Mycobacterium tuberculosis Complex (MTBc) drug resistant isolates worldwide. In Mexico, not enough information has been reported in this concern. The aim of this study was to characterize mutations related to resistance to first line drugs in MTBc isolates from Oaxaca, Mexico. MTBc isolates were identified in clinical samples from Tuberculosis (TB) patients. … …American Journal of Infectious Diseases, Vol. 17, Issue 4 · 28 Oct 2021 · 6,667 accessesView PDF Cite

Research ArticleOpen accessIn the abstractPrevalence and Antibiotic Sensitivity test of Salmonella Serovars from Enteric Fever Suspected Patients Visiting Alka Hospital, LalitpurKalpana Pandey, Vijay K. Sharma, Roshani MaharjanEnteric fever is still an important public health problem in developing countries including Nepal. A changing antibiotic susceptibility pattern of Salmonella Typhi and Salmonella Paratyphi A has increased to a great concern. To determine the prevalence and antibiotic sensitivity pattern of S. enteric serovars Typhi and Paratyphi from blood specimen in enteric fever suspected culture positive cases. A cross-sectional study … …Current Research in Microbiology, Vol. 6, Issue 2 · 30 Oct 2015 · 7,952 accessesView PDF Cite

EditorialOpen accessIn the abstractAre we Able to Harness the Immunomodulatory Power of Cytokines for Novel Autoimmune Disease Treatments?Giuseppe Nocentini, Graziella Migliorati, Carlo RiccardiSince the end of the 1970s, interleukin 2 (IL-2) has been known as a key player in T cell expansion/activation (Watson et al., 1980). In the late 1980s, some groups used IL-2 to stimulate the immune systems of tumour patients (Jacobs et al., 1986). The idea seemed brilliant and several attempts were made, but the results were disappointing (Lim et … …American Journal of Pharmacology and Toxicology, Vol. 10, Issue 2 · 22 Oct 2015 · 7,625 accessesView PDF Cite

Research ArticleOpen accessIn the abstractDrug Susceptibility Pattern of M.Tuberculosis Isolated from Patients Attending a Private HospitalD. Sureshkumar, Ram GopalakrishnanProblem statement: Drug resistance in Tuberculosis (TB) is an emerging problem that adversely affects patient outcome and public health in the developing world. Although much of tuberculosis care is provided by the private sector in India, the magnitude of drug resistance in TB in the private sector is not well described. The present study was carried out to determine the … …American Journal of Infectious Diseases, Vol. 7, Issue 4 · 22 Dec 2011 · 7,281 accessesView PDF Cite

Research ArticleOpen accessIn the abstractUnderstand the Role of Natural KillerHan Yuen Lam, Swee Keong Yeap, Noorjahan Banu Alitheen et al.Problem statement: Immunosuppression is a common approach for pathogens or cancer to escape from immune system of the infected host. Some of the antimicrobe or anticancer drugs may also weaken the body immune system. Among various types of immune cell, natural killer cells are the key component of the innate immunity which plays an important role in first line defense … …American Journal of Immunology, Vol. 6, Issue 4 · 5 Aug 2011 · 7,935 accessesView PDF Cite

Research ArticleOpen accessIn the abstractAntibiogram-Derived Radial Decision Trees: An Innovative Approach to Susceptibility Data DisplayRocco J. Perla, Paul P. BelliveauHospital antibiograms (ABGMs) are often presented in the form of large 2-factor (single organism vs. single antimicrobial) tables. Presenting susceptibility data in this fashion, although of value, does have limitations relative to drug resistant subpopulations. As the crisis of antimicrobial drug-resistance continues to escalate globally, clinicians need (1) to have access to susceptibility data that, for isolates resistant to first-line … …American Journal of Infectious Diseases, Vol. 1, Issue 2 · 30 Jun 2005 · 6,502 accessesView PDF Cite